Fig. 3
From: Differences in discontinuation of statin treatment in women and men with advanced cancer disease
Average assessed quality of life (QoL) in a current (n = 10) and former (n = 44) statin users with advanced cancer admitted to Palliative Care. b Men (current and former statin users n = 25) generally assessed their QoL at inclusion in the study worse than women (current and former statin users n = 29), Student’s t test p = 0.03. QoL was measured using the Edmonton Symptom Assessment System (ESAS), a scale from 0 to 10 where 0 is the best QoL and 10 is the worst QoL